Sirtuin-3-Mediated Cellular Metabolism Links Cardiovascular Remodeling with Hypertension

Jing Gao1, Weili Shen1

  • 1Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Biology
|May 27, 2023
PubMed

Insights

Hypertension damages the heart by altering metabolism. Reduced mitochondrial SIRT3 activity worsens this damage, increasing risks for heart failure and other cardiovascular issues.

Area of Science:

  • Cardiovascular Science
  • Metabolic Regulation
  • Molecular Biology

Background:

  • Hypertension induces cardiovascular structural and functional changes via hemodynamic and nonhemodynamic factors.
  • Metabolic alterations and pathological stressors contribute to hypertension-induced cardiovascular damage.
  • Sirtuins, particularly mitochondrial SIRT3, are key stress sensors regulating metabolic adaptation.

Purpose of the Study:

  • To review recent advances in understanding SIRT3's role in metabolic adaptation.
  • To explore the link between SIRT3 activity and hypertensive cardiovascular remodeling.
  • To highlight how SIRT3 influences endothelial dysfunction, myocardial hypertrophy, fibrosis, and heart failure.

Main Methods:

  • Review of experimental and clinical studies on SIRT3 and hypertension.
  • Analysis of molecular mechanisms underlying SIRT3-mediated metabolic regulation.
  • Examination of pathological stressors and their impact on cardiovascular remodeling.

Main Results:

  • Decreased SIRT3 activity in hypertension leads to metabolic reprogramming.
  • Reduced SIRT3 function exacerbates endothelial dysfunction and myocardial hypertrophy.
  • SIRT3 deficiency is associated with increased myocardial fibrosis and heart failure risk.

Conclusions:

  • Mitochondrial SIRT3 plays a critical role in maintaining metabolic homeostasis during hypertension.
  • Therapeutic strategies targeting SIRT3 may offer novel approaches for treating hypertensive heart disease.
  • SIRT3-mediated metabolic adaptation is a key factor in preventing or mitigating cardiovascular remodeling in hypertension.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.9K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
471